Cargando…

Creatine Kinase Is a Marker of Metabolic Syndrome in Qatari Women With and Without Polycystic Ovarian Syndrome

Objective: To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS). Design: Comparative cross-sectional analysis. Methods: Demographic and metabolic data from Qatari women aged 18–40 years from the Qatar Biobank (97 diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hail, Noora, Butler, Alexandra E., Dargham, Soha R., Abou Seif, Ahmed, Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773810/ https://www.ncbi.nlm.nih.gov/pubmed/31608014 http://dx.doi.org/10.3389/fendo.2019.00659

Ejemplares similares

The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population
por: Dargham, Soha R., et al.
Publicado: (2017)

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
por: Dargham, Soha R., et al.
Publicado: (2018)

microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
por: Butler, Alexandra E., et al.
Publicado: (2020)

Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
por: Butler, Alexandra E., et al.
Publicado: (2020)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
por: Butler, Alexandra E., et al.
Publicado: (2020)

Association of Differing Qatari Genotypes with Vitamin D Metabolites
por: Dakroury, Youssra, et al.
Publicado: (2020)

Qatari Genotype May Contribute to Complications in Type 2 Diabetes
por: Dakroury, Youssra, et al.
Publicado: (2020)

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome
por: Mir, Fayaz Ahmad, et al.
Publicado: (2022)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
por: Li, Youran, et al.
Publicado: (2022)

Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023)

Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Using Bisphenol-A to Study the Onset of Polycystic Ovarian Syndrome
por: Klenke, Ulrike, et al.
Publicado: (2011)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2022)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
por: Diboun, Ilhame, et al.
Publicado: (2021)

Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome
por: Li, Fei, et al.
Publicado: (2021)

Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome
por: Zhang, Jun-Hui, et al.
Publicado: (2022)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

The mutational analysis of mitochondrial DNA in maternal inheritance of polycystic ovarian syndrome
por: Bibi, Shaheen, et al.
Publicado: (2023)

Insulin Resistance in Polycystic Ovarian Syndrome
por: Purwar, Ananya, et al.
Publicado: (2022)

Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
por: Aversa, Antonio, et al.
Publicado: (2020)

ANGPTL4 Expression in Ovarian Granulosa Cells Is Associated With Polycystic Ovary Syndrome
por: Jiang, Qi, et al.
Publicado: (2022)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Cardiometabolic aspects of polycystic ovarian syndrome
por: Cho, Li Wei, et al.
Publicado: (2007)

Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
por: Peng, Yuanyuan, et al.
Publicado: (2022)

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome
por: Abbara, Ali, et al.
Publicado: (2019)

Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?
por: Rodier, Claire, et al.
Publicado: (2022)

Effect of quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome
por: Shah, Mohd Zahoor Ul Haq, et al.
Publicado: (2023)

Soil Properties Correlate with Microbial Community Structure in Qatari Arid Soils
por: Skariah, Sini, et al.
Publicado: (2023)

Effect and Relationship of Seasons on the High Risk of Ovarian Hyperstimulation Syndrome After Oocyte Retrieval in Patients With Polycystic Ovary Syndrome
por: Cao, Yurong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75jp6an1l6t2s0asknbh6164cs